An integrated approach to study the molecular aspects of regulatory peptides biological mechanism
Corresponding Author
Tatiana V. Vyunova
Sector of Regulatory Peptides, Department of Chemistry of Physiologically Active Substances, Institute of Molecular Genetics, Russian Academy of Sciences, Moscow, Russia
Correspondence
T.V.Vyunova, Sector of Regulatory Peptides of Department of Chemistry of Physiologically Active Substances, Institute of Molecular Genetics of the Russian Academy of Sciences, Kurchatov sq.,2, Moscow 123182, Russia.
Email: [email protected]
Search for more papers by this authorLioudmila A. Andreeva
Sector of Regulatory Peptides, Department of Chemistry of Physiologically Active Substances, Institute of Molecular Genetics, Russian Academy of Sciences, Moscow, Russia
Search for more papers by this authorKonstantin V. Shevchenko
Sector of Regulatory Peptides, Department of Chemistry of Physiologically Active Substances, Institute of Molecular Genetics, Russian Academy of Sciences, Moscow, Russia
Search for more papers by this authorNikolai F. Myasoedov
Sector of Regulatory Peptides, Department of Chemistry of Physiologically Active Substances, Institute of Molecular Genetics, Russian Academy of Sciences, Moscow, Russia
The Mental Health Research Center of the Russian Academy of Medical, Moscow, Russia
Search for more papers by this authorCorresponding Author
Tatiana V. Vyunova
Sector of Regulatory Peptides, Department of Chemistry of Physiologically Active Substances, Institute of Molecular Genetics, Russian Academy of Sciences, Moscow, Russia
Correspondence
T.V.Vyunova, Sector of Regulatory Peptides of Department of Chemistry of Physiologically Active Substances, Institute of Molecular Genetics of the Russian Academy of Sciences, Kurchatov sq.,2, Moscow 123182, Russia.
Email: [email protected]
Search for more papers by this authorLioudmila A. Andreeva
Sector of Regulatory Peptides, Department of Chemistry of Physiologically Active Substances, Institute of Molecular Genetics, Russian Academy of Sciences, Moscow, Russia
Search for more papers by this authorKonstantin V. Shevchenko
Sector of Regulatory Peptides, Department of Chemistry of Physiologically Active Substances, Institute of Molecular Genetics, Russian Academy of Sciences, Moscow, Russia
Search for more papers by this authorNikolai F. Myasoedov
Sector of Regulatory Peptides, Department of Chemistry of Physiologically Active Substances, Institute of Molecular Genetics, Russian Academy of Sciences, Moscow, Russia
The Mental Health Research Center of the Russian Academy of Medical, Moscow, Russia
Search for more papers by this authorAbstract
An integrated methodological approach to study the molecular aspects of short regulatory neuropeptides biological mechanism is proposed. The complex research is based on radioligand-receptor method of analysis and covers such points of peptides molecular activity as: specific binding of peptides to brain cells plasmatic membranes, formation of tissue specific synacton, influence of peptides (as allosteric modulators) on functionality of different neuroreceptors as well as delayed in time effects of peptides on receptor-binding activity of well-known neuroreceptor systems. Radiolabeled ligands in such complex study are the one of the best and precision instruments to uncover the molecular mechanism of multiple and multitarget biological effects of regulatory peptides. In this issue we used heptapeptide Semax as a model regulatory peptide, [3H]Ach and [3H]GABA as an effector molecules, and the rat model of stress-induced memory and behavior impairment as a morbid state. We showed the ability of Semax to modulate in a dose-dependent manner [3H]Ach and [3H]GABA specific binding to some of its corresponding receptors as well as to affect the number of [3H]GABA specific binding places on rat neurons plasmatic membranes after complex stress exposure.
CONFLICT OF INTEREST
The authors declare no conflict of interest.
REFERENCES
- 1Holzer P. Neuropeptides, microbiota, and behavior. Int Rev Neurobiol. 2016; 131: 67-89. https://doi.org/10.1016/bs.irn.2016.08.005
- 2Luczynski P, McVey Neufeld KA, Oriach CS, Clarke G, Dinan TG, Cryan JF. Growing up in a bubble: using germ-free animals to assess the influence of the gut microbiota on brain and behavior. Int J Neuropsychopharmacol. 2016; 19(8):pyw020. https://doi.org/10.1093/ijnp/pyw020
- 3Kolomin T, Shadrina M, Slominsky P, Limborska S, Myasoedov N. A new generation of drugs: synthetic peptides based on natural regulatory peptides. Neurosci Med. 2013; 4(4): 223-252.
10.4236/nm.2013.44035 Google Scholar
- 4Vyunova TV, Andreeva LA, Shevchenko KV, Shevchenko VP, Myasoedov NF, Bezuglov VV. A biotechnological procedure for preparing short peptides and their radioactively labeled analogs for estimating specific binding of Semax and its metabolites in various sections of rat brain. Radiochemistry. 2009; 51(2): 183-189.
- 5Vyunova TV, Andreeva LA, Shevchenko KV, Myasoedov NF. Synacton and individual activity of synthetic and natural corticotropins. J Mol Recognit. 2017; 30(5):e2597. https://doi.org/10.1002/jmr.2597
- 6Bezuglov VV, Akimov MG, Gretskaya NM, et al. The study of the neurotropic peptides role in cell responses regulation. Horiz Neurosci Res. 2015; 21(10): 151-170.
- 7Shadrina M, Kolomin T, Agapova T, et al. Comparison of the temporary dynamics of NGF and BDNF gene expression in rat hippocampus, frontal cortex, and retina under Semax action. J Mol Neurosci. 2010; 41(1): 30-35. https://doi.org/10.1007/s12031-009-9270-z
- 8Medvedeva EV, Dmitrieva VG, Povarova OV, et al. Effect of Semax and its C-terminal fragment Pro-Gly-Pro on the expression of VEGF family genes and their receptors in experimental focal ischemia of the rat brain. J Mol Neurosci. 2013; 49(2): 328-333. https://doi.org/10.1007/s12031-012-9853-y
- 9Dmitrieva VG, Povarova OV, Skvortsova VI, Limborska SA, Myasoedov NF, Dergunova LV. Semax and Pro-Gly-Pro activate the transcription of neurotrophins and their receptor genes after cerebral ischemia. Cell Mol Neurobiol. 2010; 30(1): 71-79. https://doi.org/10.1007/s10571-009-9432-0
- 10Glazova NY, Sebentsova EA, Manchenko DM, et al. The protective effect of Semax in a model of stress-induced impairment of memory and behavior in white rats. Biol Bull. 2018; 45(4): 394-399. https://doi.org/10.1134/S1062359018040040
- 11Vyunova TV, Andreeva LA, Shevchenko KV, Shevchenko VP, Myasoedov NF. Peptide regulation of specific ligand-receptor interactions of GABA with the plasma membranes of nerve cells. Neurochem J. 2014; 8(4): 259-264. https://doi.org/10.1134/S1819712414040114
- 12Tarasov VV, Kudryashov NV, Chubarev VN, et al. Pharmacological aspects of neuro-immune interactions. Curr Pharm Des. 2018; 24(1): 15-21. https://doi.org/10.2174/1381612823666170829135115
- 13Madva EN, Granstein RD. Nerve-derived transmitters including peptides influence cutaneous immunology. Brain Behav Immun. 2013; 34: 1-10. https://doi.org/10.1016/j.bbi.2013.03.006
- 14Vyunova TV, Shevchenko KV, Shevchenko VP, Bobrov MY, Bezuglov VV, Myasoedov NF. Specific binding of Semax in different regions of the rat brain. Dokl Biol Sci. 2006; 410(1): 376-377.
- 15Han ZY, Zoli M, Cardona A, Bourgeois JP, Changeux JP, Le Novere NJ. Localization of [3H]nicotine, [3H]cytisine, [3H]epibatidine, and [125I]alpha-bungarotoxin binding sites in the brain of Macaca mulatta. Comp Neurol. 2003; 461(1): 49-60.
- 16Tribollet E, Bertrand D, Marguerat A, Raggenbas M. Comparative distribution of nicotinic receptor subtypes during development, adulthood and aging: an autoradiographic study in the rat brain. Neuroscience. 2004; 124(2): 405-420.
- 17Sershen H, Reith ME, Hashim A, Lajtha A. Comparison of [3H]nicotine and [3H]acetylcholine binding in mouse brain: regional distribution. Res Commun Chem Pathol Pharmacol. 1985; 48(3): 345-352.
- 18Kellar KJ, Martino AM, Hall DPJ, Schwartz RD, Taylor RL. High-affinity binding of [3H]acetylcholine to muscarinic cholinergic receptors. J Neurosci. 1985; 5(6): 1577-1582.
- 19Reulecke M, Hucho F. High- and low-affinity binding of [3H]acetylcholine at nicotinic cholinergic receptors in rat brain. Neurosci Lett. 1985; 59(3): 271-276.
- 20Sharonova IN, Bukanova YV, Myasoedov NF, Skrebitskii VG. Modulation of GABA- and glycine-activated ionic currents with Semax in isolated cerebral neurons. Bull Exp Biol Med. 2018; 164(5): 612-616. https://doi.org/10.1007/s10517-018-4043-8
- 21Grigoriev VV, Petrova LN, Gabrelian AV, Zamoyski VL, Serkova TP, Bachurin SO. Effect of somatostatin on presynaptic and postsynaptic glutamate receptors and postsynaptic GABA receptors in the neurons of rat brain. Bull Exp Biol Med. 2012; 154(1): 10-12.
- 22Agatonovic-Kustrin S, Kettle C, Morton DW. A molecular approach in drug development for Alzheimer's disease. Biomed Pharmacother. 2018; 106: 553-565. https://doi.org/10.1016/j.biopha.2018.06.147
- 23Taylor SF, Tso IF. GABA abnormalities in schizophrenia: a methodological review of in vivo studies. Schizophr Res. 2015; 167(1-3): 84-90. https://doi.org/10.1016/j.schres.2014.10.011
- 24Jacobson LH, Vlachou S, Slattery DA, Li X, Cryan JF. The gamma-aminobutyric acid B receptor in depression and reward. Biol Psychiatry. 2018; 83(11): 963-976. https://doi.org/10.1016/j.biopsych.2018.02.006
- 25Slattery DA, Cryan JF. The role of GABAB receptors in depression and antidepressant-related behavioural responses. Drug Dev Res. 2006; 67(6): 477-494. https://doi.org/10.1002/ddr.20110
- 26Cryan JF, Slattery DA. GABAB receptors and depression. Current status. Adv Pharmacol. 2010; 58: 427-451. https://doi.org/10.1016/S1054-3589(10)58016-5
- 27Cryan JF, Kaupmann K. Don't worry ‘B’ happy!: a role for GABA(B) receptors in anxiety and depression. Trends Pharmacol Sci. 2005; 26(1): 36-43. https://doi.org/10.1016/j.tips.2004.11.004
- 28Gruen RJ, Wenberg K, Elahi R, Friedhoff AJ. Alterations in GABAA receptor binding in the prefrontal cortex following exposure to chronic stress. Brain Res. 1995; 684(1): 112-114.
- 29Chigr F, M'Hamed SB, Najimi M. Allosteric modulation of GABAA receptor by somatostatin is altered under stress in rat brainstem. Folia Biol (Praha). 2001; 47(6): 196-199.
- 30Levitskaya NG, Vilensky DA, Glazova NY, Andreeva LA, Kamensky AA, Myasoedov NF. Study of Semax influence on depression-like behavior of white rats in different experimental models. Problems Of Biological. Med Pharm Chem. 2011; 4: 46-51.
- 31Slominsky PA, Shadrina MI, Kolomin TA, et al. Peptides semax and selank affect the behavior of rats with 6-OHDA induced PD-like parkinsonism. Dokl Biol Sci. 2017; 474(1): 106-109.
- 32Yatsenko KA, Glazova NY, Inozemtseva LS, et al. Heptapeptide semax attenuates the effects of chronic unpredictable stress in rats. Dokl Biol Sci. 2013; 453(1): 353-357.
- 33Willner P, Towell A, Sampson D, Sophokleous S, Muscat R. Reduction of sucrose preference by chronic unpredictable mild stress, and its restoration by a tricyclic antidepressant. Psychopharmacology (Berl). 1987; 93(3): 358-364.
- 34Ogawa T, Shishioh-Ikejima N, Konishi H, et al. Chronic stress elicits prolonged activation of alpha-MSH secretion and subsequent degeneration of melanotroph. J Neurochem. 2009; 109(5): 1389-1399. https://doi.org/10.1111/j.1471-4159.2009.06057.x
